MILI HEALTHCARE LIMITED

Get an alert when MILI HEALTHCARE LIMITED files next

Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.

Next accounts due

2026-09-30 (in 4mo)

Last filed for 2024-12-31

Confirmation statement due

2027-03-24 (in 10mo)

Last made up 2026-03-10

Watchouts

None on the register

Cash

£4M

+63.8% highest in 10 filed years

Net assets

£4M

USD 3,775,702

-0.7% vs 2023

Employees

+16.4% vs 2023

Profit before tax

£73K

-92.3% lowest in 6 filed years

Net assets

10-year trend · vs Consumer Discretionary median

MILI HEALTHCARE LIMITED·Consumer Discretionary median · n=21268

Accounts

10-year trend · latest reflected 2024-12-31

Metric	2019-12-31	2020-01-01	2020-12-31	2021-01-01	2021-12-31	2022-01-01	2022-12-31	2023-01-01	2023-12-31	2024-12-31
Turnover	£9,949,007	—	£11,610,242	—	£12,547,180	—	£9,699,946	—	£15,432,596	£15,121,523
Operating profit	£673,661	—	£679,828	—	£135,082	—	£313,458	—	£950,342	£73,052
Profit before tax	£673,661	—	£679,828	—	£135,082	—	£313,655	—	£950,652	£73,304
Net profit	£509,172	—	£538,571	—	£105,064	—	£251,988	—	£728,162	-£25,749
Cash	£359,337	£359,337	£1,557,314	£1,557,314	£1,476,946	£1,476,946	£2,344,325	£2,344,325	£2,486,487	£4,073,302
Total assets less current liabilities	—	—	£2,716,237	—	£2,821,301	—	£3,073,289	—	£2,841,781	£2,822,533
Net assets	£2,177,666	—	£2,716,237	—	£2,821,301	—	£3,073,289	—	£3,801,451	£3,775,702
Equity	£2,177,666	£2,177,666	£2,716,237	£2,716,237	£2,821,301	£2,821,301	£3,073,289	£3,073,289	£3,801,451	£3,775,702
Average employees	72	—	64	—	59	—	52	—	55	64
Wages	—	—	£312,246	—	£322,100	—	£421,831	—	£455,803	£597,633
Directors' remuneration	—	—	—	—	£9,595	—	£79,870	—	£81,990	£85,702

Figures converted to GBP from USD at 0.748 per USD (Frankfurter spot rate) — hover any figure for the original. — indicates the figure wasn't present under that line item in that period. About these numbers

Year-on-year

FY2023 → FY2024 · period ending 2024-12-31 vs 2023-12-31

Turnover

-2%

£15,432,596 £15,121,523
Cash

+63.8%

£2,486,487 £4,073,302

highest in 10 filed years
Net assets

-0.7%

£3,801,451 £3,775,702
Employees

+16.4%

55 64
Operating profit

-92.3%

£950,342 £73,052

lowest in 6 filed years
Profit before tax

-92.3%

£950,652 £73,304

lowest in 6 filed years
Wages

+31.1%

£455,803 £597,633

highest in 5 filed years

Each % is (latest − prior) ÷ |prior| for the line item as filed. The comparison is only shown when the latest and prior accounts cover broadly equal-length periods — short or long stubs (typical around incorporation or a year-end change) are suppressed rather than misrepresented. Lines a company doesn't report are omitted. About these numbers

Ratios

Computed from the line items above — sparklines read oldest → newest

Ratio	2019-12-31	2020-01-01	2020-12-31	2021-01-01	2021-12-31	2022-01-01	2022-12-31	2023-01-01	2023-12-31	2024-12-31
Operating margin	6.8%	—	5.9%	—	1.1%	—	3.2%	—	6.2%	0.5%
Net margin	5.1%	—	4.6%	—	0.8%	—	2.6%	—	4.7%	-0.2%
Return on capital employed	—	—	25.0%	—	4.8%	—	10.2%	—	33.4%	2.6%
Gearing (liabilities / total assets)	—	—	—	—	—	—	—	—	-33.8%	-33.8%
Current ratio	—	—	—	—	—	—	—	—	2.06x	1.98x

Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.

Audit & accounting basis

Accounting basis: FRS 102
Reporting scope: Standalone (parent only)
Auditor: HaysMac LLP
Audit opinion: Unqualified (clean)
Going concern: Affirmed
“Despite the ongoing war in Ukraine, the Company has successfully stabilised its operations. While risks remain (territorial limitations, reduced consumer demand, logistics, security), stabilising factors (Ukraine's projected GDP growth 2.5-3.5% for 2025, adapted operations) support its ability to continue as a going concern.”

Significant events

“Mili Healthcare Limited demonstrated strong operational resilience and strategic positioning within Ukraine's pharmaceutical market in 2024. Maintained market presence through diversified operations (retail pharmacy sales $14.5M, government hospital procurement). Strengthened position in oncology, ranking 2nd in government tender volume. Portfolio grew to 36 products in 2024.”

Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers

People

2 active · 11 resigned

Name	Role	Appointed	Born	Nationality
HICKSON, Stephen John Dudley	Director	2015-11-16	Jun 1947	British
LYTOVSKA, Olga	Director	2021-12-17	Apr 1971	Ukrainian

Show 11 resigned officers

Name	Role	Appointed	Resigned
BROWN, Amanda	Secretary	2001-10-17	2005-09-08
VAIL, Elizabeth Lorna	Secretary	2005-09-08	2008-12-16
CREDITREFORM SECRETARIES LIMITED	Corporate Nominee Secretary	2001-10-12	2001-10-17
BROWN, Amanda	Director	2001-10-17	2005-09-08
GROBMAN, Mikhail	Director	2005-11-29	2012-12-21
MYKHAYLISHYN, Stanislav	Director	2011-05-25	2015-11-16
SHIFFERS, Anthony Graham	Director	2005-11-29	2008-12-16
SHIFFERS, Anthony Graham	Director	2001-10-17	2005-11-29
VATCHENKO, Anna	Director	2013-10-01	2015-11-16
YANSUPOV, Rufat	Director	2013-06-18	2015-11-16
CREDITREFORM LIMITED	Corporate Nominee Director	2001-10-12	2001-10-17

Ownership

Persons with significant control

Name	Kind	Nature of control	Notified	Status
Olga Lytovska	Individual	Shares 75–100%, Voting 75–100%, Appoints directors	2019-03-04	Active
Mr Vitali Spirydau	Individual	Shares 25–50%, Voting 25–50%, Appoints directors	2017-11-14	Ceased 2022-03-10
Mr Borys Lytovskyi	Individual	Shares 50–75%, Voting 50–75%, Appoints directors	2016-04-06	Ceased 2019-03-04

Filing timeline

Last 20 of 108 total filings

Date	Type	Category	Description
2026-03-12	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2025-09-24	AA	accounts	Accounts with accounts type full	PDF
2025-03-31	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2025-03-31	CH01	officers	Change person director company with change date	PDF
2025-03-31	PSC04	persons-with-significant-control	Change to a person with significant control	PDF
2024-09-27	AA	accounts	Accounts with accounts type full	PDF
2024-03-25	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2024-03-25	PSC04	persons-with-significant-control	Change to a person with significant control	PDF
2024-03-25	CH01	officers	Change person director company with change date	PDF
2023-09-27	AA	accounts	Accounts with accounts type full	PDF
2023-09-18	AD01	address	Change registered office address company with date old address new address	PDF
2023-03-21	CS01	confirmation-statement	Confirmation statement with no updates	PDF
2023-03-03	AA	accounts	Accounts with accounts type full	PDF
2023-03-01	DISS40	gazette	Gazette filings brought up to date
2023-02-28	GAZ1	gazette	Gazette notice compulsory
2023-01-19	PSC04	persons-with-significant-control	Change to a person with significant control	PDF
2023-01-19	CH01	officers	Change person director company with change date	PDF
2023-01-19	CH01	officers	Change person director company with change date	PDF
2022-05-26	CH01	officers	Change person director company with change date	PDF
2022-05-26	PSC04	persons-with-significant-control	Change to a person with significant control	PDF

Public-record activity

Raw counts from Companies House — last 12–24 months

Filings: 2
Capital events: 0
Officers appointed: 0
Officers resigned: 0

Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.

Official Companies House page